Viewing Study NCT03847818


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-05 @ 11:31 AM
Study NCT ID: NCT03847818
Status: UNKNOWN
Last Update Posted: 2019-03-01
First Post: 2019-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer
Sponsor: Shandong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module